Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma

Clinical trial NCT03280212 · UNKNOWN

Trial details

NCT number: NCT03280212
Sponsor: Unity Health Toronto
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Subdural Hematoma

Start date: 2017-03-06
Primary completion: 2018-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.